Events
30
Aug
2024
Cracking the Code of Uncontrolled Hypertension
![Event img](https://assets.radcliffecardiology.com/s3fs-public/event/2024-07/Web%20Thumbnail%20Baxdrostat%20DELV-21975.png?VersionId=q0XUvYVmX765eWn.gJmfsuXwN_d9.7oA)
Radcliffe Medical Education is hosting a Satellite Symposium entitled 'Cracking the Code of Uncontrolled Hypertension' at ESC 2024, in London. Join us in the Prague room on Friday 30 August 2024 at 15:15.
Overview
This symposium will delve into the complexities of uncontrolled hypertension, exploring its clinical impact, treatment barriers, and underlying drivers. It will feature a case study of a patient with previously well-managed hypertension now facing challenges, followed by a faculty-led discussion on clinical risks and guideline-directed treatment options.
Join Prof Thomas Weber (Klinikum Wels-Grieskirchen, Wels, AT); Prof John Flack (Southern Illinois University School of Medicine, Springfield, US); Prof Alta Schutte (University of New South Wales, Sydney, AU) and Prof Bryan Williams (University College London, London, UK) as they examine the limitations of current therapeutic approaches, including issues like clinical inertia and the constraints of standard care, while addressing future strategies and innovations in hypertension management.
Programme
Welcome and Introduction – Prof Thomas Weber
The True Impact of Uncontrolled Hypertension – Prof Thomas Weber and Prof Alta Schutte
What Drives Uncontrolled Hypertension and What’s in Our Tool Kit? – Prof Bryan Williams
Current Treatment Barriers and Limitations in Uncontrolled Hypertension – Prof John Flack
Summary and Close – Prof Thomas Weber
Learning Objectives
After attending this symposium, physicians will be able to:
- Describe the long-term clinical impact of uncontrolled hypertension
- Apply guideline-directed management to a patient case study
- Evaluate the challenges and limitations of current management options for uncontrolled hypertension
- Describe the role of aldosterone in uncontrolled hypertension
This activity is supported by an unrestricted educational grant from AstraZeneca. AstraZeneca has had no involvement in the selection of the speakers, the development of the activity, the agenda or the materials.
Start date
End date
Location
ExCel Centre
Royal Victoria Dock, 1 Western Gateway
London E16 1XL
United Kingdom